Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2015, Article ID 728260, 6 pages
http://dx.doi.org/10.1155/2015/728260
Case Report

Successful Treatment of Multifocal Histiocytic Sarcoma Occurring after Renal Transplantation with Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) Followed by Allogeneic Hematopoietic Stem Cell Transplantation

1Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of California San Diego, San Diego, CA, USA
2Division of Hematology-Oncology, Department of Medicine, University of California San Diego, San Diego, CA, USA
3Department of Pathology, University of California San Diego, San Diego, CA, USA
4Blood and Marrow Transplantation Program, Moores Cancer Center, 3855 Health Sciences Drive, No. 0960, La Jolla, CA 92093-0960, USA

Received 22 March 2015; Accepted 31 May 2015

Academic Editor: Ray Lowenthal

Copyright © 2015 Julia Tomlin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Akiba, H. Harada, A. Kawahara et al., “Histiocytic sarcoma of the parotid gland region,” Pathology International, vol. 61, no. 6, pp. 373–376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. H. Swerdlow, E. Campo, N. L. Harris et al., WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC, Lyon, France, 2008.
  3. J. L. Hornick, E. S. Jaffe, and C. D. M. Fletcher, “Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy,” American Journal of Surgical Pathology, vol. 28, no. 9, pp. 1133–1144, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. E. C. C. Castro, C. Blazquez, J. Boyd et al., “Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature,” Pediatric and Developmental Pathology, vol. 13, no. 3, pp. 225–237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Cheuk, N. Walford, J. Lou et al., “Primary histiocytic lymphoma of the central nervous system: a neoplasm frequently overshadowed by a prominent inflammatory component,” American Journal of Surgical Pathology, vol. 25, no. 11, pp. 1372–1379, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. M. S. Wilson, L. M. Weiss, K. C. Gatter, D. Y. Mason, R. F. Dorfman, and R. A. Warnke, “Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies,” Cancer, vol. 66, no. 3, pp. 530–536, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Y. F. L. De Vos, M. N. Gerding, J. W. Arends, and J. J. Wegman, “Histiocytic sarcoma localised in the thyroid: a case report,” Annals of Hematology, vol. 87, no. 8, pp. 681–682, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Yu and S. J. Yang, “A case of primary histiocytic sarcoma arising from thyroid gland,” Pathology and Oncology Research, vol. 16, no. 1, pp. 127–132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. B. A. Alexiev, C. J. Sailey, S. A. McClure, R. A. Ord, X. F. Zhao, and J. C. Papadimitriou, “Primary histiocytic sarcoma arising in the head and neck with predominant spindle cell component,” Diagnostic Pathology, vol. 2, no. 1, article 7, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Cao, C. Eshoa, C. Schultz, J. Black, Y. Zu, and C.-C. Chang, “Primary central nervous system histiocytic sarcoma with relapse to mediastinum: a case report and review of the literature,” Archives of Pathology and Laboratory Medicine, vol. 131, no. 2, pp. 301–305, 2007. View at Google Scholar · View at Scopus
  11. R. G. M. de Slegte, J. J. Calame, A. Burger-de Geus, and J. Valk, “Histiocytic sarcoma of the brain in childhood,” European Journal of Radiology, vol. 7, no. 2, pp. 121–124, 1987. View at Google Scholar · View at Scopus
  12. S. Gill-Samra, T. Ng, M. Dexter et al., “Histiocytic sarcoma of the brain,” Journal of Clinical Neuroscience, vol. 19, no. 10, pp. 1456–1458, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. R. D. Snyder, G. M. Mavligit, M. Valdivieso, J. U. Gutterman, and J. S. Burke, “Histiocytic lymphoma in the brain as the only manifestation of relapse following remission maintainance with BCG immunotherapy,” Cancer, vol. 39, no. 5, pp. 1997–2000, 1977. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Varadachari, M. Palutke, A. R. W. Climie, R. W. Weise, and J. L. Chason, “Immunoblastic sarcoma (histiocytic lymphoma) of the brain with B cell markers. Case report,” Journal of Neurosurgery, vol. 49, no. 6, pp. 887–892, 1978. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Veluvolu, B. D. Collier, A. T. Isitman, and R. S. Hellman, “‘Butterfly’ pattern of uptake in posterior brain scan in diffuse histiocytic lymphoma,” Clinical Nuclear Medicine, vol. 10, no. 1, pp. 50–51, 1985. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Wang, T. Li, H. Chen, and Q. Liu, “A case of primary central nervous system histiocytic sarcoma,” Clinical Neurology and Neurosurgery, vol. 114, no. 7, pp. 1074–1076, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. P. J. Yang, J. E. Knake, T. O. Gabrielsen et al., “Primary and secondary histiocytic lymphoma of the brain: CT features,” Radiology, vol. 154, no. 3, pp. 683–686, 1985. View at Publisher · View at Google Scholar · View at Scopus
  18. P. K. Pellitteri, A. Ferlito, P. J. Bradley, A. R. Shaha, and A. Rinaldo, “Management of sarcomas of the head and neck in adults,” Oral Oncology, vol. 39, no. 1, pp. 2–12, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. Vos, S. L. Abbondanzo, C. L. Barekman, J. W. Andriko, M. Miettinen, and N. S. Aguilera, “Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163,” Modern Pathology, vol. 18, no. 5, pp. 693–704, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Adam, P. Szturz, J. Vaníček et al., “Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: a single-center study of seven cases,” Acta Oncologica, vol. 52, no. 5, pp. 994–1001, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Cantu, P. J. Lupo, M. Bilgi, M. J. Hicks, C. E. Allen, and K. L. McClain, “Optimal therapy for adults with langerhans cell histiocytosis bone lesions,” PLoS ONE, vol. 7, no. 8, Article ID e43257, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. M. Egeler, J. de Kraker, and P. A. Voute, “Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution,” Medical and Pediatric Oncology, vol. 21, no. 4, pp. 265–270, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Gadner, N. Grois, U. Pötschger et al., “Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification,” Blood, vol. 111, no. 5, pp. 2556–2562, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Morimoto, S. Ikushima, N. Kinugawa et al., “Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study,” Cancer, vol. 107, no. 3, pp. 613–619, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Pardanani, R. L. Phyliky, C.-Y. Li, and A. Tefferi, “2-Chlorodeoxyadenosine therapy for disseminated langerhans cell histiocytosis,” Mayo Clinic Proceedings, vol. 78, no. 3, pp. 301–306, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Saven and C. Burian, “Cladribine activity in adult Langerhans-cell histiocytosis,” Blood, vol. 93, no. 12, pp. 4125–4130, 1999. View at Google Scholar · View at Scopus
  27. A. Zeidan, J. Bolaños-Meade, Y. Kasamon et al., “Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic sarcoma,” Leukemia and Lymphoma, vol. 54, no. 3, pp. 655–657, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Kramer, M. E. F. Prins, J. G. Kapsenberg et al., “Persistent Epstein-Barr virus infection and a histiocytic sarcoma in a renal transplant recipient,” Cancer, vol. 55, no. 3, pp. 503–509, 1985. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Congyang, W. Xinggui, L. Hao, and H. Weihua, “Synchronous histiocytic sarcoma and diffuse large B cell lymphoma involving the stomach: a case report and review of the literature,” International Journal of Hematology, vol. 93, no. 2, pp. 247–252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. A. L. Feldman, D. A. Arber, S. Pittaluga et al., “Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone,” Blood, vol. 111, no. 12, pp. 5433–5439, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Takahashi and S. Nakamura, “Histiocytic sarcoma: an updated literature review based on the 2008 WHO classification,” Journal of Clinical and Experimental Hematopathology, vol. 53, no. 1, pp. 1–8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Wang, C. B. Hutchinson, Q. Huang et al., “Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular/genetic evidence suggestive of a ‘transdifferentiation’ during the clonal evolution,” Leukemia and Lymphoma, vol. 51, no. 5, pp. 802–812, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Zhang, J. McGuirk, S. Ganguly, and D. L. Persons, “Histiocytic/dendritic cell sarcoma arising from follicular lymphoma involving the bone: a case report and review of literature,” International Journal of Hematology, vol. 89, no. 4, pp. 529–532, 2009. View at Publisher · View at Google Scholar · View at Scopus